{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T04:30:53Z","timestamp":1786681853853,"version":"build-2736575974"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019978","name":"Shanghai Pudong New Area Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019978","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Osteosarcopenia, defined by the coexistence of sarcopenia and osteoporosis, is increasingly recognized as a high-risk geriatric musculoskeletal syndrome. Although it is commonly diagnosed by applying separate criteria for sarcopenia and osteoporosis, whether osteosarcopenia has a distinct systemic metabolic phenotype remains unclear. This study aimed to characterize the serum metabolomic profile of osteosarcopenia and to identify discovery-level candidate metabolites that may distinguish osteosarcopenia from osteoporosis alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a cross-sectional untargeted metabolomics study using high-resolution liquid chromatography\u2013mass spectrometry in 104 older adults, including healthy controls (HC, n = 30), participants with osteoporosis only (OP, n = 30), sarcopenia only (IS, n = 14), and osteosarcopenia (OS, n = 30). Because the IS group was relatively small, comparisons involving IS were treated as exploratory and hypothesis-generating. The primary mechanistic and biomarker analyses focused on the OP versus OS comparison. Differential metabolites, enriched pathways, and preliminary discriminatory performance were assessed using multivariate modeling, false discovery rate correction, pathway enrichment analysis, covariate-adjusted regression, and receiver operating characteristic analysis. Age, sex, body mass index, and estimated glomerular filtration rate were included as covariates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Osteosarcopenia showed a distinct serum metabolomic profile, particularly when compared with osteoporosis alone. In the OP versus OS comparison, differential metabolites were mainly involved in amino acid metabolism, energy metabolism, purine metabolism, and membrane lipid remodeling. Key alterations included reduced branched-chain amino acids, decreased hypoxanthine, increased creatine, and changes in sphingomyelin and phosphatidylcholine species. Pathway enrichment analysis highlighted valine, leucine, and isoleucine degradation; arginine and proline metabolism; and purine metabolism as significantly enriched pathways. Among the discovery-level candidate metabolites, hypoxanthine and leucine showed apparent discriminatory potential for distinguishing OS from OP, with area under the curve values of 0.87 and 0.79, respectively. These values should be interpreted as discovery-set estimates rather than externally validated diagnostic performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Osteosarcopenia was associated with a multi-pathway serum metabolic signature that differed from osteoporosis alone, supporting the possibility that osteosarcopenia represents an integrated musculoskeletal phenotype rather than merely the additive coexistence of muscle and bone loss. The identified metabolites provide preliminary mechanistic insight and discovery-level biomarker candidates, but they require targeted quantitative validation and external cohort confirmation before clinical application.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial registration<\/jats:title>\n                    <jats:related-object>\n                      <jats:ext-link>http:\/\/www.chictr.org.cn<\/jats:ext-link>\n                      , identifier ChiCTR2500113401.\n                    <\/jats:related-object>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1865132","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T04:23:07Z","timestamp":1786681387000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A distinct serum metabolic profile characterizes osteosarcopenia: identifying potential metabolic biomarkers"],"prefix":"10.3389","volume":"17","author":[{"given":"Hui","family":"Gao","sequence":"first","affiliation":[{"name":"School of Gongli Hospital Medical Technology, University of Shanghai for Science and Technology","place":["Shanghai, China"]},{"name":"Department of Orthopedics I, Gongli Hospital of Shanghai Pudong New Area","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Gongli Hospital Medical Technology, University of Shanghai for Science and Technology","place":["Shanghai, China"]},{"name":"Department of Orthopedics I, Gongli Hospital of Shanghai Pudong New Area","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Guo","sequence":"additional","affiliation":[{"name":"Artificial Intelligence and Omics Research Center, AigenX Bioscience Co., Ltd.","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhisheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Gongli Hospital Medical Technology, University of Shanghai for Science and Technology","place":["Shanghai, China"]},{"name":"Department of Orthopedics I, Gongli Hospital of Shanghai Pudong New Area","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangang","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Gongli Hospital Medical Technology, University of Shanghai for Science and Technology","place":["Shanghai, China"]},{"name":"Department of Orthopedics I, Gongli Hospital of Shanghai Pudong New Area","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihong","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Gongli Hospital Medical Technology, University of Shanghai for Science and Technology","place":["Shanghai, China"]},{"name":"Department of Orthopedics I, Gongli Hospital of Shanghai Pudong New Area","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiding","family":"Zhao","sequence":"additional","affiliation":[{"name":"School of Gongli Hospital Medical Technology, University of Shanghai for Science and Technology","place":["Shanghai, China"]},{"name":"Department of Orthopedics I, Gongli Hospital of Shanghai Pudong New Area","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Gongli Hospital Medical Technology, University of Shanghai for Science and Technology","place":["Shanghai, China"]},{"name":"Department of Orthopedics I, Gongli Hospital of Shanghai Pudong New Area","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12567","article-title":"Osteosarcopenia: Epidemiology, diagnosis, and treatment\u2014facts and numbers","volume":"11","author":"Kirk","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/13697137.2021.1951204","article-title":"A pas de deux of osteoporosis and sarcopenia: Osteosarcopenia","volume":"25","author":"Laskou","year":"2022","journal-title":"Climacteric"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155638","article-title":"Sarcopenia, osteoporosis and frailty","volume":"145","author":"Gielen","year":"2023","journal-title":"Metabolism"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.17043","article-title":"The prevention of osteoporosis and sarcopenia in older adults","volume":"69","author":"Coll","year":"2021","journal-title":"J Am Geriatr Soc"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/nu16091328","article-title":"Three-year mortality of older hospitalized patients with osteosarcopenia: Data from the OsteoSys study","volume":"16","author":"Pourhassan","year":"2024","journal-title":"Nutrients"},{"key":"B6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/jcsm.13392","article-title":"Global epidemiological features and impact of osteosarcopenia: A comprehensive meta\u2010analysis and systematic review","volume":"15","author":"Chen","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13787","article-title":"Osteosarcopenia in chronic kidney disease: An overlooked syndrome","volume":"16","author":"Caldiroli","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/agm2.12080","article-title":"Osteosarcopenia: A case of geroscience","volume":"2","author":"Kirk","year":"2019","journal-title":"Aging Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"9473","DOI":"10.1038\/s41598-025-93988-1","article-title":"Predictive efficacy of different diagnostic criteria for sarcopenia in osteoporosis and fractures","volume":"15","author":"Zhan","year":"2025","journal-title":"Sci Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.afos.2025.05.004","article-title":"Definition and diagnosis of sarcopenia: Asia-pacific perspectives","volume":"11","author":"Huang","year":"2025","journal-title":"Osteoporosis Sarcopenia"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155558","article-title":"Defining and diagnosing sarcopenia: Is the glass now half full","volume":"143","author":"Barazzoni","year":"2023","journal-title":"Metabolism"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa755","article-title":"Osteosarcopenia: Where osteoporosis and sarcopenia collide","volume":"60","author":"Clynes","year":"2021","journal-title":"Rheumatology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"102118","DOI":"10.1016\/j.arr.2023.102118","article-title":"Mouse models of accelerated aging in musculoskeletal research for assessing frailty, sarcopenia, and osteoporosis \u2013 a review","volume":"93","author":"Y\u0131lmaz","year":"2024","journal-title":"Ageing Res Rev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26146924","article-title":"Rethinking osteoporosis drugs: Can we simultaneously address sarcopenia","volume":"26","author":"Gavrilov","year":"2025","journal-title":"IJMS"},{"key":"B15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41413-025-00455-8","article-title":"Research progress on sarcopenia in the musculoskeletal system","volume":"13","author":"Mao","year":"2025","journal-title":"Bone Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1530\/joe-25-0234","article-title":"Muscle\u2013bone biochemical crosstalk in osteosarcopenia: Focusing on mechanisms and potential therapeutic strategies","volume":"266","author":"Dong","year":"2025","journal-title":"J Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102587","article-title":"Sarcopenia and the biological determinants of aging: A narrative review from a geroscience perspective","volume":"103","author":"Nunes-Pinto","year":"2025","journal-title":"Ageing Res Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2024.01.004","article-title":"A perspective on muscle phenotyping in musculoskeletal research","volume":"35","author":"Foessl","year":"2024","journal-title":"Trends Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413575","article-title":"Metabolomics as an important tool for determining the mechanisms of human skeletal muscle deconditioning","volume":"22","author":"Alldritt","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102148","article-title":"Blood biomarkers for sarcopenia: A systematic review and meta-analysis of diagnostic test accuracy studies","volume":"93","author":"Lian","year":"2024","journal-title":"Ageing Res Rev"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.993253","article-title":"Application of metabolomics in osteoporosis research","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103111","article-title":"Association between the metabolome and bone mineral density in a Chinese population","volume":"62","author":"Mei","year":"2020","journal-title":"eBioMedicine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s40520-024-02923-3","article-title":"Combining untargeted and targeted metabolomic profiling reveals principal differences between osteopenia, osteoporosis and healthy controls","volume":"37","author":"Tan","year":"2025","journal-title":"Aging Clin Exp Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13567","article-title":"Novel metabolic and lipidomic biomarkers of sarcopenia","volume":"15","author":"Hsu","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-024-00337-3","article-title":"Metabolic signatures and potential biomarkers of sarcopenia in suburb-dwelling older Chinese: Based on untargeted GC\u2013MS and LC\u2013MS","volume":"14","author":"Han","year":"2024","journal-title":"Skeletal Muscle"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2022.112047","article-title":"Exploring biomarkers of osteosarcopenia in older adults attending a frailty clinic","volume":"172","author":"Inoue","year":"2023","journal-title":"Exp Gerontol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22157958","article-title":"Common muscle metabolic signatures highlight arginine and lysine metabolism as potential therapeutic targets to combat unhealthy aging","volume":"22","author":"Tokarz","year":"2021","journal-title":"IJMS"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.70105","article-title":"Role of branched\u2010chain amino acids in mitigating osteosarcopenia: An experimental study using ovariectomised mice models","volume":"16","author":"Lee","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/biom12010041","article-title":"Metabolomics coupled with pathway analysis provides insights into sarco-osteoporosis metabolic alterations and estrogen therapeutic effects in mice","volume":"12","author":"Wei","year":"2021","journal-title":"Biomolecules"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13135","article-title":"Older adults with sarcopenia have distinct skeletal muscle phosphodiester, phosphocreatine, and phospholipid profiles","volume":"19","author":"Hinkley","year":"2020","journal-title":"Aging Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13054-024-05222-5","article-title":"Creatinine production rate is an integrative indicator to monitor muscle status in critically ill patients","volume":"29","author":"Yamamoto","year":"2025","journal-title":"Crit Care"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.580167","article-title":"Acetate revisited: A key biomolecule at the nexus of metabolism, epigenetics and oncogenesis\u2014part 1: acetyl-CoA, acetogenesis and acyl-CoA short-chain synthetases","volume":"11","author":"Moffett","year":"2020","journal-title":"Front Physiol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202000493r","article-title":"Intramuscular short\u2010chain acylcarnitines in elderly people are decreased in (pre\u2010)frail females, but not in males","volume":"34","author":"Van Der Hoek","year":"2020","journal-title":"FASEB J"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2018.01.018","article-title":"High expression of CPT1b in skeletal muscle in metabolically healthy older subjects","volume":"45","author":"B\u00e9try","year":"2019","journal-title":"Diabetes Metab"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.14336\/ad.2024.0407","article-title":"Aging-related sarcopenia: Metabolic characteristics and therapeutic strategies","volume":"16","author":"Chen","year":"2025","journal-title":"Aging Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12877-022-02953-4","article-title":"Specific lysophosphatidylcholine and acylcarnitine related to sarcopenia and its components in older men","volume":"22","author":"Meng","year":"2022","journal-title":"BMC Geriatr"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.816045","article-title":"Specific metabolites involved in antioxidation and mitochondrial function are correlated with frailty in elderly men","volume":"9","author":"Meng","year":"2022","journal-title":"Front Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.647743","article-title":"Hypoxanthine induces muscular ATP depletion and fatigue via UCP2","volume":"12","author":"Yin","year":"2021","journal-title":"Front Physiol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11090628","article-title":"A distinctive human metabolomics alteration associated with osteopenic and osteoporotic patients","volume":"11","author":"Aleidi","year":"2021","journal-title":"Metabolites"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.cmet.2024.04.004","article-title":"Gut microbial alterations in arginine metabolism determine bone mechanical adaptation","volume":"36","author":"Wang","year":"2024","journal-title":"Cell Metab"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185206","article-title":"Increased plasma proline concentrations are associated with sarcopenia in the elderly","volume":"12","author":"Toyoshima","year":"2017","journal-title":"PloS One"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1530\/ey.16.5.5","article-title":"Osteoporosis and skeletal dysplasia caused by pathogenic variants in SGMS2","volume":"4","author":"Pekkinen","year":"2019","journal-title":"JCI Insight"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/nu14245321","article-title":"Correlation between mild cognitive impairment and sarcopenia: The prospective role of lipids and basal metabolic rate in the link","volume":"14","author":"Wang","year":"2022","journal-title":"Nutrients"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.752540","article-title":"The role of sphingolipid metabolism in bone remodeling","volume":"9","author":"Qi","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26094428","article-title":"Towards precision in sarcopenia assessment: The challenges of multimodal data analysis in the era of AI","volume":"26","author":"Caputo","year":"2025","journal-title":"IJMS"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1865132\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T04:23:08Z","timestamp":1786681388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1865132\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":45,"alternative-id":["10.3389\/fendo.2026.1865132"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1865132","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"article-number":"1865132"}}